The Checkup by Singlecare

SEPTEMBER 7, 2023

Compare Mounjaro alternatives | Other GLP-1 receptor agonists | Oral biguanides | SGLT2 inhibitors | DPP4 inhibitors | GLP-1 receptor agonists for weight loss | Natural alternatives | How to switch meds Diet and exercise alone aren’t enough to control Type 2 diabetes. Fortunately, drug therapy for diabetes has come a long way.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

PharmaShots

APRIL 14, 2023

Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)

FDA 40

FDA 40

PharmaShots

JUNE 16, 2023

Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B

FDA 40

FDA Labelling 40

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

PharmaShots

JANUARY 27, 2023

Magenta Therapeutics Pauses the P-I/II Study in AML Patients Date: Jan 27, 2023 | Tags: Magenta Therapeutics, MGTA-117, AML, Clinical Trial, P-I/II Ipsen Receives CHMP Negative Opinion for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva Date: Jan 27, 2023 | Tags: Ipsen, Palovarotene, Fibrodysplasia Ossificans Progressiva, Regulatory, CHMP, (..)

FDA 40

FDA Immunization 40

The Checkup by Singlecare

NOVEMBER 2, 2023

These drugs mimic GLP-1, a hormone responsible for regulating appetite and food intake, leading to weight loss and improved control of blood sugar levels in people with Type 2 diabetes. So how do you know if they’re right for your patients (even those who aren’t diabetic)?

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

The Checkup by Singlecare

AUGUST 31, 2023

How to get Mounjaro without insurance Mounjaro (tirzepatide) is a brand-name prescription drug FDA-approved to control blood sugar levels in people with Type 2 diabetes. Some insurance plans and Medicare Part D drug plans cover Mounjaro for Type 2 diabetes, but some don’t. Is Mounjaro covered by insurance?

Insurance 98

Insurance Compounding Insurance Coverage Labelling 98

Pharmaceutical Technology

JANUARY 17, 2023

Bimagrumab is an activin receptor type 2B (ACVR2B or EC 2.7.11.30) antagonist that offers a unique mechanism of action within the obesity market. Despite its high price tag, bimagrumab’s unique features set it apart from currently marketed therapies. Mounjaro is anticipated to launch in the US later this year or by early 2024.

Hospitals 52

Hospitals 52

PharmaShots

MARCH 17, 2023

5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted

FDA 40

FDA Labelling 40

PharmD Live

DECEMBER 21, 2021

With an annual price per patient of nearly $56,000 per year, patients’ families are looking for solutions for their loved ones–with a huge price tag. Insulin, first introduced in 1921, 100 years later, 2021, diabetes monitoring devices are added to Medicare’s durable medical equipment list coverage. Aduhelm earns FDA approval.

FDA 52

FDA Hospitals 52

The Checkup by Singlecare

MARCH 21, 2023

Pain management depends on adequately identifying the type of pain one is experiencing , which can be broken down into 4 broad categories: acute, chronic, neuropathic, and radicular pain. Lortab ( hydrocodone-acetaminophen ) is a type of opioid medication. mg to 2 mg every 4 hours as needed – adjust according to response IM, SubQ: 0.2

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

The Checkup by Singlecare

JANUARY 19, 2023

People with diabetes or prediabetes experience hyperglycemia. High blood sugar is caused by various factors, such as certain foods, stress, or, more commonly for those with Type 1 diabetes , not taking enough insulin. Diabetes medications can be expensive, but there are ways to save on your medications.

Immunization 105

Immunization Hospitals Communication 105

The Checkup by Singlecare

JUNE 21, 2023

The condition causes higher levels of androgen hormone production, resulting in symptoms such as irregular menstrual cycles, acne, excess hair growth, cysts, skin tags, thinning hair, skin darkening, and infertility. In addition to eating a healthy diet and regular exercise, certain diabetes medications, including Ozempic, may help.

Insurance 98

Insurance FDA Compounding Compounding Pharmacies 98

PharmaShots

MARCH 10, 2023

Vertex Receives the US FDA’s IND Clearance of VX-264 for the Treatment of Type 1 Diabetes Date: Mar 10, 2023 | Tags: Vertex, VX-264, Type 1 Diabetes, Regulatory, US, FDA, IND Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies Date: Mar 10, 2023 | Tags: Alnylam, Medison Pharma, RNAi Therapies, Onpattro, patisiran, (..)

FDA 40

FDA Vaccines 40

The Checkup by Singlecare

MARCH 7, 2024

It was approved by the Food and Drug Administration (FDA) in 2017 for treating Type 2 diabetes. You may need up to 2 mg of Ozempic per week, depending on your diabetes management plan. You may need up to 2 mg of Ozempic per week, depending on your diabetes management plan.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Packaging Insurance Coverage 52

The Checkup by Singlecare

MAY 8, 2023

Still, widespread and uncontrolled prescribing in the 1990s triggered the first wave of an epidemic in the misuse and overdoses of specific types of analgesic medications known as opioids. Non-drug measures, such as exercise, ice, heat, massage, and weight loss, should be emphasized in managing any type of pain, as appropriate.

Controlled Substances 52

Controlled Substances Dosage Labelling FDA 52

pharmaphorum

DECEMBER 7, 2021

They also found that sildenafil use reduced the likelihood of Alzheimer’s in people with coronary artery disease, hypertension and type 2 diabetes – which are known risk factors for this type of dementia – but also in those without these underlying conditions.

Compounding 52

Compounding Insurance FDA 52

Pharmaceutical Technology

NOVEMBER 30, 2022

The drug was approved to treat type 2 diabetes mellitus in May. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The drug was approved to treat type 2 diabetes mellitus in May. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions.

Insurance 98

Insurance Labelling Communication FDA 98